Get started
Author

Miles Parkes

Interleukin-10 Autoantibodies and HLA-DRB1*01:03 in Inflammatory Bowel Disease
2026 · Nima Gharahdaghi, Pai-Jui Yeh, et al. · New England Journal of Medicine · 16
Magnetic resonance imaging-based simplified MaRIA scores are associated with future surgery in Crohn’s disease, but modest correlation with ileo-colonoscopic inflammation limits their utility in clinical trials: results from the PROFILE trial
2026 · Megha Bhandari, Mohmmed Tauseef Sharip, et al. · Journal of Crohn s and Colitis · 2
Bayesian prior elicitation on the efficacy of medical therapies in perianal fistulizing Crohn’s disease
2026 · Nurulamin M Noor, Haiyan Zheng, et al. · Journal of Crohn s and Colitis · 1
Orofacial granulomatosis associated with Crohn’s disease: clinical phenotype and response to biologics and Janus kinase inhibitor therapy in a large multi-center cohort
2026 · Robert D Lees, Priyanka Patel, et al. · Journal of Crohn s and Colitis
Resolving inflammatory bowel disease risk variants to genes and cell types
2026 · Laura Fachal, Rui Zhang, et al. · medRxiv
PDF
Divergent effects of HLA-DQA1:p.Gln198Glu on trajectory in inflammatory bowel disease
2026 · Laura Fachal, Benjamin Zare, et al. · Research Square
PDF
Disease phenotype affects treatment of late-onset inflammatory bowel disease: Analysis of a large UK cohort
2026 · Peter F G Foulser, Laura Martinez-Gili, et al. · Inflammatory Bowel Diseases
P668 Differential efficacy of biologic agents for Inflammatory Bowel Disease Unclassified and comparison with Ulcerative Colitis: a propensity score analysis of 4054 patients from the UK IBD BioResource
2023 · C Kapizioni, R Desoki, et al. · Journal of Crohn s and Colitis
PDF
Works count: 8
Citation count: 19
H-index: 2
I10-index: 1
Year
Topic
Type